by Rob Blaich | Apr 20, 2017 | CCARM News, Home News, ICS News
Scientists at St. Boniface Hospital Albrechtsen Research Centre and the University of Manitoba have developed a drug that combats 2 of the top 10 “priority pathogens” recently defined by the World Health Organization (WHO) as antiobiotic-resistant bacteria requiring...
